Bareilly Pharmaceuticals Private Limited
About Bareilly Pharmaceuticals Private Limited
Data last updated:
Bareilly Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 18 March 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP1998PTC023244. Its GSTIN is 09AACCB2671F1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Arun Kumar Agarwal (Whole-Time Director) and Vinay Kumar Agarwal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 15 Lda Complex 193 Gali Nawaban, Bareilly, Uttar Pradesh, India – 243003.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.81 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹17.93 Lakh (net margin 0.8%) and EBITDA of ₹37.1 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No 15 Lda Complex 193 Gali Nawaban, Bareilly, Uttar Pradesh, India – 243003
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bareilly Pharmaceuticals Private Limited
The main business activity of Bareilly Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bareilly Pharmaceuticals Private Limited FY 2025 filings available
Bareilly Pharmaceuticals Private Limited reported revenue of ₹22.81 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Bareilly Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 7% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bareilly Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹37.1 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.93 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bareilly Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bareilly Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bareilly Pharmaceuticals Private Limited
Bareilly Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gadiya Pharmaceuticals Private Limited | ₹23.04 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Chengalpattu, Tamil Nadu, India |
| Glumex Pharmaceuticals Manufacturing Pvt Ltd. | ₹23.04 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Vasai, Maharashtra, India |
| Zeal Medipharma (Export) Private Limited | ₹22.94 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Thane, Maharashtra, India |
| Interface Pharmaceuticals Pvt Ltd | ₹22.92 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | New Delhi, Delhi, India |
| Vertech Health Solutions India Private Limited | ₹22.89 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Bareilly Pharmaceuticals Private Limited this company | ₹22.81 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Bareilly, Uttar Pradesh, India |
| Accura Care Pharmaceuticals Private Limited | ₹22.8 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Delhi, India |
| Hexa Health Care Private Limited | ₹22.74 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Mumbai, Maharashtra, India |
| Innorex Pharmaceuticals Private Limited | ₹22.73 Cr (FY 2025) | •••• | •••• | 90.0% | •••• | Mumbai, Maharashtra, India |
| Advanov Pharma Private Limited | ₹22.68 Cr (FY 2024) | •••• | •••• | 107.0% | •••• | Ahmedabad, Gujarat, India |
| Avis Lifecare Private Limited | ₹22.66 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Bareilly Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bareilly Pharmaceuticals Private Limited
Bareilly Pharmaceuticals Private Limited is audited by SUNIL SHARDA & CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUNIL SHARDA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Bareilly Pharmaceuticals Private Limited
Bareilly Pharmaceuticals has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Kumar Agarwal | Whole-Time Director | 18 Mar 1998 | 28 Years 6 Months | Current |
| Vinay Kumar Agarwal | Whole-Time Director | 18 Jul 2001 | 25 Years 2 Months | Current |
| Sanjeev Kumar Agarwal | Whole-Time Director | 18 Mar 1998 | 28 Years 6 Months | Current |
| Naveen Kumar Agarwal | Whole-Time Director | 18 Mar 1998 | 28 Years 6 Months | Current |
| Rajeev Kumar Agarwal | Whole-Time Director | 18 Jul 2001 | 25 Years 2 Months | Current |
Ownership and Shareholding of Bareilly Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bareilly Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2022 | Hdfc Bank Limited | ₹1 Cr | Open |
| 17 Feb 2006 | State Bank of India | ₹50 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Bareilly Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Bareilly Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bareilly Pharmaceuticals Private Limited
Bareilly Pharmaceuticals Private Limited has 5 board changes on record since 1998: 5 appointments. The latest: Rajeev Kumar Agarwal was appointed as Whole-Time Director on 18 Jul 2001.
Credit Ratings, Litigation & Regulatory Alerts for Bareilly Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bareilly Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bareilly Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bareilly Pharmaceuticals Private Limited
Bareilly Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCB2671F1ZU | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bareilly Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bareilly Pharmaceuticals Private Limited
Bareilly Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 18 March 1998 (28+ years old) and is registered under CIN U24232UP1998PTC023244.
Bareilly Pharmaceuticals reported revenue of ₹22.81 Cr for FY 2024 (up 7% YoY).
Bareilly Pharmaceuticals has 5 current directors:
- Arun Kumar Agarwal - Whole-Time Director
- Vinay Kumar Agarwal - Whole-Time Director
- Sanjeev Kumar Agarwal - Whole-Time Director
- Naveen Kumar Agarwal - Whole-Time Director
- Rajeev Kumar Agarwal - Whole-Time Director
Bareilly Pharmaceuticals reported a net profit of ₹17.93 Lakh (net margin 0.8%) and EBITDA of ₹37.1 Lakh (EBITDA margin 1.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bareilly Pharmaceuticals is 10% over three years and 5% over five years. In the latest year (FY 2024) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bareilly Pharmaceuticals is 09AACCB2671F1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Bareilly Pharmaceuticals is U24232UP1998PTC023244. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bareilly Pharmaceuticals was incorporated on 18 March 1998, making it 28+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Bareilly Pharmaceuticals by revenue are Gadiya Pharmaceuticals Private Limited, Glumex Pharmaceuticals Manufacturing Pvt Ltd, Zeal Medipharma (Export) Private Limited, Interface Pharmaceuticals Pvt Ltd, Vertech Health Solutions India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Rajeev Kumar Agarwal was appointed as Whole-Time Director on 18 Jul 2001. Vinay Kumar Agarwal was appointed as Whole-Time Director on 18 Jul 2001. Arun Kumar Agarwal was appointed as Whole-Time Director on 18 Mar 1998. Bareilly Pharmaceuticals has 5 board changes on record in total.
The registered office of Bareilly Pharmaceuticals is at Shop No 15 Lda Complex 193 Gali Nawaban, Bareilly, Uttar Pradesh, India – 243003.